Danaparoid and condition aggravated Patient Reports February 10, 2010

Danaparoid Side Effects Report #5228777-6
Danaparoid side effect was reported by a Consumer or non-health professional from FRANCE on Jan 22, 2007. Male patient, 67 years of age, was diagnosed with thrombocytopenia and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia, condition aggravated, haematuria, thrombocytopenia. Danaparoid dosage: unknown. During the same period patient was treated with OFLOXACIN, OMEPRAZOLE, ENOXAPARIN. Patient was hospitalized. Patient recovered.

Danaparoid Side Effects Report #5119938-5
Danaparoid side effect was reported by a Consumer or non-health professional from CANADA on Aug 29, 2006. Female patient, 78 years of age, was diagnosed with heparin-induced thrombocytopenia and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: condition aggravated, heparin-induced thrombocytopenia, pulmonary embolism , respiratory gas exchange disorder. Danaparoid dosage: unknown. Patient was hospitalized. Patient recovered.

Danaparoid Side Effects Report #5135919-X
Danaparoid side effect was reported by a Consumer or non-health professional from ISRAEL on Oct 12, 2006. Female patient, 63 years of age, was diagnosed with heparin-induced thrombocytopenia and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: condition aggravated, platelet count decreased, pneumonia , thrombosis. Danaparoid dosage: unknown. During the same period patient was treated with HEPARIN, NOREPINEPHRINE BITARTRATE, OXACILLIN, AMIODARONE. Patient recovered.

Danaparoid Side Effects Report #5086058-8
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Aug 11, 2006. Female patient, 93 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: condition aggravated, disseminated intravascular coagulation, haemoglobin decreased, haemorrhage. Danaparoid dosage: unknown. During the same period patient was treated with PIPERACILLIN, AZTREONAM, ANTITHROMBIN III. Patient died.


Danaparoid Side Effects Report #5042515-1
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on May 18, 2006. Female patient, 93 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: condition aggravated, disseminated intravascular coagulation, haemorrhage. Danaparoid dosage: unknown. During the same period patient was treated with PIPERACILLIN, AZTREONAM, ANTITHROMBIN III. Patient died.

Danaparoid Side Effects Report #4968053-X
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Dec 27, 2005. Female patient, 92 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: condition aggravated, gastrointestinal haemorrhage, haemoglobin decreased. Danaparoid dosage: unknown. During the same period patient was treated with CIPROFLOXACIN HYDROCHLORIDE, PRODIF, PLATELETS, PLASMA PROTEIN FRACTION, RED BLOOD CELLS, PLASMA PROTEIN FRACTION. Patient died.

Danaparoid Side Effects Report #5116966-0
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Sept 19, 2006. Female patient, 88 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: condition aggravated, disseminated intravascular coagulation, hypokalaemia. Danaparoid dosage: unknown. During the same period patient was treated with ANTITHROMBIN III, DOPAMINE, OMEPRAZOLE, FUROSEMIDE. Patient recovered.

Danaparoid Side Effects Report #5024835-X
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on June 01, 2006. Female patient, 88 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: condition aggravated, disseminated intravascular coagulation, hypokalaemia. Danaparoid dosage: unknown. During the same period patient was treated with ANTITHROMBIN III, DOPAMINE, OMEPRAZOLE, FUROSEMIDE. Patient recovered.

Danaparoid Side Effects Report #5042516-3
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on June 05, 2006. Male patient, 86 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: condition aggravated, disseminated intravascular coagulation, haemorrhage, infection . Danaparoid dosage: unknown. During the same period patient was treated with IMMUNE GLOBULIN INTRAVENOUS, GABEXATE MESILATE, CARBENIN, ULINASTATIN, PLASMA PROTEIN FRACTION. Patient died.


Danaparoid Side Effects Report #5031765-6
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Dec 27, 2005. Male patient, 85 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: condition aggravated, haemorrhage. Danaparoid dosage: unknown. During the same period patient was treated with CIPROFLOXACIN HYDROCHLORIDE, IMMUNE GLOBULIN INTRAVENOUS, MICAFUNGIN, PLASMA PROTEIN FRACTION, GABEXATE MESILATE, PLATELETS, MINOCYCLINE HYDROCHLORIDE, CEFPIROME SULPHATE. Patient died.

Danaparoid Side Effects Report #5077936-4
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Aug 02, 2006. Male patient, 82 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, condition aggravated, haemoglobin decreased, platelet count increased, upper gastrointestinal haemorrhage, white blood cell count increased. Danaparoid dosage: unknown. During the same period patient was treated with MICAFUNGIN, METHYLPREDNISOLONE SUCCINATE, PLATELETS, PLASMA PROTEIN FRACTION, CARBENIN. Patient died.

Danaparoid Side Effects Report #5118898-0
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Sept 19, 2006. Female patient, 82 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, blood urea increased, condition aggravated, haemoglobin decreased, pneumonia , upper gastrointestinal haemorrhage, white blood cell count increased. Danaparoid dosage: unknown. During the same period patient was treated with DORIPENEM HYDRATE, ROXATIDINE ACETATE. Patient died.

Danaparoid Side Effects Report #5027820-7
Danaparoid side effect was reported by a Health Professional from JAPAN on June 05, 2006. Male patient, 82 years of age, was diagnosed with disseminated intravascular coagulation, pulmonary mycosis, shock, pneumonia  and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: condition aggravated, haemoglobin decreased, upper gastrointestinal haemorrhage. Danaparoid dosage: unknown. During the same period patient was treated with MICAFUNGIN, METHYLPREDNISOLONE SUCCINATE, PLATELETS, PLASMA PROTEIN FRACTION, CARBENIN. Patient died.

Danaparoid Side Effects Report #4976157-0
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Mar 27, 2006. Male patient, 80 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia, blood urea increased, condition aggravated, gastrointestinal haemorrhage, haemorrhagic diathesis, hyperkalaemia, jaundice , white blood cell count decreased. Danaparoid dosage: unknown. During the same period patient was treated with PLASMA PROTEIN FRACTION, SULPERAZON, PREDNISOLONE ACETATE OPHTHALMIC, AZASETRON HYDROCHLORIDE, PIRARUBICIN, VINCRISTINE SULPHATE, CYCLOPHOSPHAMIDE, CARBENIN. Patient was hospitalized. Patient died.


Danaparoid Side Effects Report #5108484-0
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Aug 18, 2006. Female patient, 78 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, condition aggravated, gastrointestinal haemorrhage, haematocrit decreased, haemoglobin decreased, multi-organ failure, red blood cell count decreased, sepsis . Danaparoid dosage: unknown. During the same period patient was treated with MEROPENEM TRIHYDRATE, FAMOTIDINE, CLINDAMYCIN PHOSPHATE, PAZUFLOXACIN, HYDROCORTISONE SUCCINATE, MICAFUNGIN, GABEXATE MESILATE, CARPERITIDE. Patient was hospitalized. Patient died.

Danaparoid Side Effects Report #5110463-4
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Aug 11, 2006. Female patient, 78 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: condition aggravated, gastrointestinal haemorrhage, multi-organ failure, sepsis . Danaparoid dosage: unknown. During the same period patient was treated with MEROPENEM TRIHYDRATE, FAMOTIDINE, CLINDAMYCIN PHOSPHATE, PAZUFLOXACIN, HYDROCORTISONE SUCCINATE, MICAFUNGIN, GABEXATE MESILATE, CARPERITIDE. Patient was hospitalized. Patient died.

Danaparoid Side Effects Report #5116971-4
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Sept 15, 2006. Female patient, 78 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: condition aggravated, gastrointestinal haemorrhage, multi-organ failure, sepsis . Danaparoid dosage: unknown. During the same period patient was treated with MEROPENEM TRIHYDRATE, FAMOTIDINE, CLINDAMYCIN PHOSPHATE, PAZUFLOXACIN, HYDROCORTISONE SUCCINATE, MICAFUNGIN, GABEXATE MESILATE, CARPERITIDE. Patient was hospitalized. Patient recovered.

Danaparoid Side Effects Report #5047256-2
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on June 22, 2006. Male patient, 77 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: catheter related complication, condition aggravated, fibrin d dimer increased, haemorrhage, pelvic fluid collection, renal failure. Danaparoid dosage: unknown. During the same period patient was treated with GABEXATE MESILATE, ANTITHROMBIN III, BROMHEXINE HYDROCHLORIDE, DOPAMINE, DOBUTAMINE, NORADRENALINE, ALBUMIN, TIENAM. Patient recovered.

Danaparoid Side Effects Report #4995842-8
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Apr 25, 2006. Male patient, 77 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia, condition aggravated, disease progression, disseminated intravascular coagulation, gastrointestinal haemorrhage, haemorrhage subcutaneous, haemorrhagic diathesis, platelet count decreased. Danaparoid dosage: unknown. During the same period patient was treated with MEROPENEM, CIMETIDINE, EPOETIN BETA, HEPARIN. Patient died.


Danaparoid Side Effects Report #5030468-1
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on May 31, 2006. Male patient, 77 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: condition aggravated, haemorrhage, renal failure. Danaparoid dosage: unknown. During the same period patient was treated with GABEXATE MESILATE, ANTITHROMBIN III, BROMHEXINE HYDROCHLORIDE, DOPAMINE, DOBUTAMINE, NORADRENALINE, ALBUMIN, PRIMAXIN. Patient recovered.

Danaparoid Side Effects Report #4967758-4
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Mar 26, 2006. Female patient, 76 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: blood bilirubin increased, blood creatinine increased, blood potassium increased, blood urea increased, cardiac disorder, condition aggravated, haematocrit decreased, haemoglobin decreased, haemorrhage. Danaparoid dosage: unknown. During the same period patient was treated with PANCURONIUM BROMIDE, GABEXATE MESILATE, CEFOZOPRAN HYDROCHLORIDE, THEOPHYLLINE, PROPOFOL. Patient died.

Danaparoid Side Effects Report #5027829-3
Danaparoid side effect was reported by a Health Professional from JAPAN on June 01, 2006. Female patient, 76 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: blood bilirubin increased, blood creatinine increased, blood potassium increased, blood urea increased, cardiac disorder, condition aggravated, haematocrit decreased, haemoglobin decreased, haemorrhage. Danaparoid dosage: unknown. During the same period patient was treated with PANCURONIUM BROMIDE, GABEXATE MESILATE, CEFOZOPRAN HYDROCHLORIDE, THEOPHYLLINE, PROPOFOL. Patient died.

Danaparoid Side Effects Report #5113491-8
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Sept 05, 2006. Male patient, 74 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia postoperative, blood lactate dehydrogenase increased, condition aggravated, hepatic function abnormal, malnutrition, platelet count decreased, postoperative infection, renal impairment. Danaparoid dosage: unknown. During the same period patient was treated with IMIPENEM, ANTITHROMBIN III, IMMUNE GLOBULIN INTRAVENOUS, MENATETRENONE, HYDROCORTISONE PHOSPHATE, GABEXATE MESILATE, CLINDAMYCIN, CIPROFLOXACIN HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

Danaparoid Side Effects Report #5051299-2
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on June 22, 2006. Male patient, 70 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: condition aggravated, gallbladder disorder, haemoglobin decreased, haemorrhagic diathesis, hepatic ischaemia, liver disorder. Danaparoid dosage: unknown. During the same period patient was treated with CEFEPIROME SULPHATE, ISEPAMICIN SULPHATE, MINOPHAGEN C, GLUTATHIONE, MIDAZOLAM HYDROCHLORIDE, VECURONIUM BROMIDE, DOPAMINE, VERAPAMIL HYDROCHLORIDE. Patient recovered.


Danaparoid Side Effects Report #5076374-8
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on July 27, 2006. Male patient, 70 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: condition aggravated, disease progression, haemorrhagic diathesis, hepatic ischaemia, liver disorder. Danaparoid dosage: unknown. During the same period patient was treated with CEFPIROME SULPHATE, ISEPAMICIN SULPHATE, MINOPHAGEN C, GLUTATHIONE, MIDAZOLAM HYDROCHLORIDE, VECURONIUM BROMIDE, DOPAMINE, VERAPAMIL HYDROCHLORIDE. Patient recovered.

Danaparoid Side Effects Report #5113495-5
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Sept 13, 2006. Female patient, 68 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time shortened, aspartate aminotransferase increased, blood alkaline phosphatase increased, condition aggravated, deep vein thrombosis , international normalised ratio increased, lymphocyte percentage decreased, neutrophil percentage increased, platelet count decreased. Danaparoid dosage: unknown. During the same period patient was treated with GABEXATE MESILATE, ANTITHROMBIN III, DOPAMINE, CARBENIN, CLINDAMYCIN PHOSPHATE, ACYCLOVIR, INSULIN, FLUCONAZOLE. Patient recovered.

Danaparoid Side Effects Report #5047255-0
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on June 27, 2006. Male patient, 64 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: cardiac tamponade, condition aggravated, infection , leukaemia, liver disorder, renal impairment. Danaparoid dosage: unknown. During the same period patient was treated with GABEXATE MESILATE, AMIKACIN SULPHATE, PIPERACILLIN, IDARUBICIN, CYTARABINE, MEROPENEM, TOBRAMYCIN, ANTITHROMBIN III. Patient died.

Danaparoid Side Effects Report #5047257-4
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on June 26, 2006. Male patient, 64 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: condition aggravated, loss of consciousness. Danaparoid dosage: unknown. During the same period patient was treated with DIAZEPAM, DEXAMETHASONE, FAMOTIDINE, MIDAZOLAM HYDROCHLORIDE, CYTARABINE, CEFTAZIDIME, RAMOSETRON HYDROCHLORIDE. Patient was hospitalized. Patient died.

Danaparoid Side Effects Report #5056233-7
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on June 06, 2006. Male patient, 61 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: condition aggravated, haemoglobin decreased, haemorrhage, neoplasm malignant. Danaparoid dosage: unknown. During the same period patient was treated with ULINASTATIN, SIVELESTAT, ANTITHROMBIN III, IMMUNE GLOBULIN INTRAVENOUS, FLOMEX, FAMOTIDINE, PROPOFOL. Patient died.


Danaparoid Side Effects Report #4968087-5
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Nov 19, 2003. Male patient, 61 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: condition aggravated, haemorrhage, malignant neoplasm progression. Danaparoid dosage: unknown. During the same period patient was treated with ULINASTATIN, SIVELESTAT, ANTITHROMBIN III, IMMUNE GLOBULIN INTRAVENOUS, FLOMOXEF, FAMOTIDINE, PROPOFOL. Patient died.

Danaparoid Side Effects Report #5033184-5
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on June 12, 2006. Male patient, 61 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia, blood bilirubin increased, condition aggravated, pulmonary alveolar haemorrhage, renal impairment. Danaparoid dosage: unknown. During the same period patient was treated with ANTITHROMBIN III, PIPERACILLIN, CLINDAMYCIN. Patient was hospitalized. Patient recovered.

Danaparoid Side Effects Report #5031766-8
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Dec 12, 2005. Male patient, 60 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: condition aggravated, haemorrhage, leukaemia. Danaparoid dosage: unknown. During the same period patient was treated with OMEPRAZOLE, NEO NICHIPHAGEN C, HYDROCORTISONE SUCCINATE, RED BLOOD CELLS, PLASMA PROTEIN FRACTION, NEUPOGEN, IMIPENEM. Patient died.

Danaparoid Side Effects Report #5153401-0
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Oct 30, 2006. Male patient, 57 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: condition aggravated, haemoglobin decreased, haemorrhage, hepatic function abnormal, multi-organ failure, neoplasm malignant, renal impairment. Danaparoid dosage: unknown. During the same period patient was treated with GABEXATE MESILATE, NAFAMOSTAT MESILATE, DOPAMINE, OMEPRAZOLE, CEFOZOPRAN HYDROCHLORIDE, ANTITHROMBIN III, ULINASTATIN. Patient died.

Danaparoid Side Effects Report #5063640-5
Danaparoid side effect was reported by a Physician from JAPAN on July 06, 2006. Male patient, 56 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: blood bilirubin increased, blood creatinine increased, blood urea increased, condition aggravated, haemoglobin decreased, upper gastrointestinal haemorrhage, white blood cell count increased. Danaparoid dosage: unknown. During the same period patient was treated with NAFAMOSTAT MESILATE, ANTITHROMBIN III, FAMOTIDINE. Patient died.


Danaparoid Side Effects Report #4974425-X
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Jan 05, 2004. Male patient, 56 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: condition aggravated, haemoglobin decreased, pre-existing disease. Danaparoid dosage: unknown. During the same period patient was treated with NAFAMOSTAT MESILATE, ANTITHROMBIN III, FAMOTIDINE. Patient died.

Danaparoid Side Effects Report #5020454-X
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Apr 04, 2006. Female patient, 56 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: blood bilirubin increased, condition aggravated, gastric ulcer haemorrhage, haematocrit decreased, haemoglobin decreased, platelet count decreased, protein total decreased, sepsis , white blood cell count decreased. Danaparoid dosage: unknown. During the same period patient was treated with SULPERAZON, FAMOTIDINE, CARBAZOCHROME SULFONATE, TRANEXAMIC ACID, FLURBIPROFEN, NEUPOGEN, METHYLPREDNISOLONE SUCCINATE, ISEPAMICIN SULPHATE. Patient died.

Danaparoid Side Effects Report #4941617-5
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Feb 23, 2006. Male patient, 53 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: cerebral haemorrhage, condition aggravated, disease recurrence, disseminated intravascular coagulation. Danaparoid dosage: unknown. During the same period patient was treated with GABEXATE MESILATE, GABEXATE MESILATE, ARBEKACIN SULPHATE, OMEPRAZOLE, PREDNISOLONE. Patient recovered.

Danaparoid Side Effects Report #4948452-2
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Mar 07, 2006. Male patient, 53 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: cerebral haemorrhage, condition aggravated, disseminated intravascular coagulation. Danaparoid dosage: unknown. During the same period patient was treated with GABEXATE MESILATE, GABEXATE MESILATE, ARBEKACIN SULPHATE, OMEPRAZOLE, PREDNISOLONE, VANCOMYCIN HYDROCHLORIDE, PAZUFLOXACIN. Patient died.

Danaparoid Side Effects Report #5153402-2
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Oct 30, 2006. Female patient, 49 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, condition aggravated, gamma-glutamyltransferase increased, hepatic function abnormal, liver disorder. Danaparoid dosage: unknown. During the same period patient was treated with GABEXATE MESILATE, ANTITHROMBIN III, MINOCYCLINE, CILASTATIN W, OMEPRAZOLE, NAFAMOSTAT MESILATE, SIVELESTAT, DOPAMINE. Patient was hospitalized. Patient died.


Danaparoid Side Effects Report #4576350-5
Danaparoid side effect was reported by a Physician from on Feb 01, 2005. Male patient, 43 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: condition aggravated, leukaemia, sepsis . Danaparoid dosage: unknown. During the same period patient was treated with HYDROCORTISONE SUCCINATE, CHLORPHENIRAMINE MALEATE, AMPHOTERICIN B, PANTHENOL, VITAJECT, ELEMENMIC, VANCOMYCIN HYDROCHLORIDE, POTASSIUM CHLORIDE. Patient died.

Danaparoid Side Effects Report #5123364-2
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Sept 05, 2006. Male patient, 40 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood lactate dehydrogenase increased, condition aggravated, disease progression, disseminated intravascular coagulation, hepatic function abnormal, platelet count increased, protein total decreased, renal impairment. Danaparoid dosage: unknown. During the same period patient was treated with AMPICILLIN, IMMUNE GLOBULIN INTRAVENOUS, GABEXATE MESILATE, ANTITHROMBIN III, ULINASTATIN, HAPTOGLOBIN. Patient died.

Danaparoid Side Effects Report #5024840-3
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on June 01, 2006. Male patient, 40 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: condition aggravated, disseminated intravascular coagulation, renal impairment, sepsis . Danaparoid dosage: unknown. During the same period patient was treated with UNASYN, IMMUNE GLOBULIN INTRAVENOUS, GABEXATE MESILATE, ANTITHROMBIN III, ULINASTATIN, HAPTOGLOBIN. Patient died.

Danaparoid Side Effects Report #5116965-9
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Sept 19, 2006. Male patient, 36 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: condition aggravated, disseminated intravascular coagulation, haemolytic anaemia, hepatic function abnormal, multi-organ failure, pancreatitis acute, sepsis . Danaparoid dosage: unknown. During the same period patient was treated with ANTITHROMBIN III, ULINASTATIN, CILASTATIN W, NAFAMOSTAT MESILATE, HYDROCORTISONE PHOSPHATE, IMMUNE GLOBULIN INTRAVENOUS. Patient died.

Danaparoid Side Effects Report #5115458-2
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Sept 13, 2006. Male patient, 17 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, condition aggravated, hepatic function abnormal. Danaparoid dosage: unknown. During the same period patient was treated with DOPAMINE, CEFPIROME SULPHATE, ANTITHROMBIN III, FAMOTIDINE, METHYLPREDNISOLONE SUCCINATE, ULINASTATIN, OMEPRAZOLE, GABEXATE MESILATE. Patient died.

Danaparoid Side Effects Report #5148279-5
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Oct 30, 2006. Male patient, 17 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, condition aggravated, gastrointestinal haemorrhage, multi-organ failure. Danaparoid dosage: unknown. During the same period patient was treated with DOPAMINE, CEFPIROME SULPHATE, ANTITHROMBIN III, FAMOTIDINE, METHYLPREDNISOLONE SUCCINATE, ULINASTATIN, OMEPRAZOLE, GABEXATE MESILATE. Patient died.

Danaparoid Side Effects Report #4886909-3
Danaparoid side effect was reported by a Consumer or non-health professional from FRANCE on Jan 12, 2006. Female patient, 71 years of age, was diagnosed with cardiovascular disorder and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: condition aggravated, embolism, heparin-induced thrombocytopenia, jaundice , leg amputation, pain . Danaparoid dosage: unknown. During the same period patient was treated with HEPARIN. Patient died.

Danaparoid Side Effects Report #5104110-5
Danaparoid side effect was reported by a Consumer or non-health professional from FRANCE on Aug 28, 2006. Male patient, 89 years of age, was treated with Danaparoid. After drug was administered, patient experienced the following side effects: condition aggravated, heparin-induced thrombocytopenia. Danaparoid dosage: unknown. During the same period patient was treated with PANTOPRAZOLE, FUROSEMIDE, FERROUS FUMARATE, POTASSIUM CHLORIDE. Patient was hospitalized. Patient recovered.

Danaparoid Side Effects Report #5116967-2
Danaparoid side effect was reported by a Health Professional from JAPAN on Sept 19, 2006. Male patient, 74 years of age, was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia postoperative, condition aggravated, disseminated intravascular coagulation, haematuria, hepatic function abnormal, malnutrition, postoperative infection, renal impairment. Danaparoid dosage: unknown. During the same period patient was treated with ANTITHROMBIN III, IMMUNE GLOBULIN INTRAVENOUS, MENATETRENONE, HYDROCORTISONE PHOSPHATE, GABEXATE MESILATE, CLINDAMYCIN, CIPROFLOXACIN HYDROCHLORIDE, TEICOPLANIN. Patient was hospitalized. Patient recovered.